One-Day Treatment of Herpes Drug Found Effective

MARCH 01, 2006
Susan Farley

Famciclovir (Famvir), in a single-dose treatment, has been proven to stop the progression to a full-blown outbreak of recurrent genital herpes (rGH) as well as to shorten the duration of the outbreak. Thus far, famciclovir is the only treatment effective for rGH in a single dose. A multicenter, randomized, double-blind, placebo-controlled study compared the 1-g dose for 1-day famciclovir with placebo. When patients with rGH initiated treatment with famciclovir within 6 hours of the first sign of outbreak, famciclovir reduced healing time of nonaborted lesions by 2 days. A higher percentage of patients experienced aborted lesions in the famciclovir group (23.3%) than in the placebo group (12.7%). In fact, patients taking famciclovir experienced a reduction in duration of all symptoms: itching, pain, burning, tingling, and tenderness—3.3 days versus 5.4 days in the placebo group. Lead investigator Fred Aoki, MD, of the University of Manitoba (Canada), concluded, "Famvir was effective in a single-day dose because it provided a full course of therapy upfront when the virus is most active."

Ms. Farley is a freelance medical writer based in Wakefield, RI.




SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.